These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15324602)

  • 61. Alzheimer's disease, apolipoprotein E and hormone replacement therapy.
    Depypere H; Vierin A; Weyers S; Sieben A
    Maturitas; 2016 Dec; 94():98-105. PubMed ID: 27823753
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.
    Asthana S; Craft S; Baker LD; Raskind MA; Birnbaum RS; Lofgreen CP; Veith RC; Plymate SR
    Psychoneuroendocrinology; 1999 Aug; 24(6):657-77. PubMed ID: 10399774
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hormonal influences on cognition and risk for Alzheimer's disease.
    Janicki SC; Schupf N
    Curr Neurol Neurosci Rep; 2010 Sep; 10(5):359-66. PubMed ID: 20535591
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of estrogens for the prevention and treatment of Alzheimer's disease.
    Monk D; Brodaty H
    Dement Geriatr Cogn Disord; 2000; 11(1):1-10. PubMed ID: 10629355
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Estrogen replacement therapy for Alzheimer disease in postmenopausal women.
    Owens CT
    Ann Pharmacother; 2002; 36(7-8):1273-6. PubMed ID: 12086563
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oestrogens and dementia.
    Henderson VW
    Novartis Found Symp; 2000; 230():254-65; discussion 265-73. PubMed ID: 10965513
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease.
    Mecocci P; Polidori MC
    Biochim Biophys Acta; 2012 May; 1822(5):631-8. PubMed ID: 22019723
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease.
    Schneider LS; Farlow MR; Henderson VW; Pogoda JM
    Neurology; 1996 Jun; 46(6):1580-4. PubMed ID: 8649552
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

  • 70. More than a decade of estrogen neuroprotection.
    Simpkins JW; Singh M
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S131-6. PubMed ID: 18631989
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cognitive and functional decline and their relationship in patients with mild Alzheimer's dementia.
    Liu-Seifert H; Siemers E; Sundell K; Price K; Han B; Selzler K; Aisen P; Cummings J; Raskin J; Mohs R
    J Alzheimers Dis; 2015; 43(3):949-55. PubMed ID: 25125457
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Estrogens against Alzheimer disease? The female sexual hormone as a protective neurohormone].
    Behl C
    MMW Fortschr Med; 2001 May; 143 Suppl 2():33-5. PubMed ID: 11434254
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The evolution of preclinical Alzheimer's disease: implications for prevention trials.
    Sperling R; Mormino E; Johnson K
    Neuron; 2014 Nov; 84(3):608-22. PubMed ID: 25442939
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluating the Role of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease.
    Osmanovic-Barilar J; Salkovic-Petrisi M
    Drugs Aging; 2016 Nov; 33(11):787-808. PubMed ID: 27709466
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease.
    Wroolie TE; Kenna HA; Williams KE; Rasgon NL
    Am J Geriatr Psychiatry; 2015 Nov; 23(11):1117-26. PubMed ID: 26209223
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Potential use of estrogen-like drugs for the prevention of Alzheimer's disease.
    Smith JD; Levin-Allerhand JA
    J Mol Neurosci; 2003; 20(3):277-81. PubMed ID: 14501008
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hormone Therapy and Effects on Sporadic Alzheimer's Disease in Postmenopausal Women: Importance of Nomenclature.
    Yare K; Woodward M
    J Alzheimers Dis; 2020; 73(1):23-37. PubMed ID: 31744009
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The central nervous system and HRT.
    Palacios S; Cifuentes I; Menendez C; von Helde S
    Int J Fertil Womens Med; 2000; 45(1):13-21. PubMed ID: 10721740
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Noncholinergic treatment options for Alzheimer's disease.
    Sano M
    J Clin Psychiatry; 2003; 64 Suppl 9():23-8. PubMed ID: 12934971
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease.
    Gillette-Guyonnet S; Andrieu S; Dantoine T; Dartigues JF; Touchon J; Vellas B;
    Alzheimers Dement; 2009 Mar; 5(2):114-21. PubMed ID: 19328438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.